Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1549230 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,211,770
+$336,745 QoQ
Shares Held
35,756
+30.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#108
of 198 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Derivatives in NAMS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$4,107,468
PutShares
121,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. NAMS ranks #85 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NAMS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,211,770 35,756
2026-06-30 $4,107,468 121,200
2026-03-31 $875,025 27,336
2025-12-31 $1,189,878 33,919
2025-09-30 $1,157,906 40,714
2025-06-30 $1,087,577 60,054
2025-03-31 $2,638,071 128,875
2024-12-31 $1,480,320 57,600
2024-12-31 $914,071 35,567
2024-12-31 $1,480,320 57,600